John Matthew Ringman MD
Professor of Neurology at the Memory and Aging Center at the Keck School of Medicine of USC
Join to View Full Profile
1520 San Pablo StSte 3000Los Angeles, CA 90033
Phone+1 323-457-5710
Fax+1 323-442-5736
Dr. Ringman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Neurology, 1994 - 1997- Baylor College of MedicineInternship, Internal Medicine, 1993 - 1994
McGill University Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1997 - 2025
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Curcumin in Patients With Mild to Moderate Alzheimer's Disease Start of enrollment: 2003 Jul 01
- Dominantly Inherited Alzheimer Network (DIAN)
- A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Cerebral hypoperfusion, brain structural integrity, and cognitive impairment in older APOE4 carriers.Ioannis Pappas, Trevor Lohman, Shubir Dutt, Arunima Kapoor, Allison C Engstrom
Geroscience. 2025-04-12 - 3 citationsMRI free water mediates the association between diffusion tensor image analysis along the perivascular space and executive function in four independent middle to aged ...Xiaodan Liu, Pauline Maillard, Giuseppe Barisano, Arvind Caprihan, Steven Cen
Alzheimer's & Dementia. 2025-02-01 - Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease.Andrew J Petkus, Anup N Sonti, Lucy Montoya, Bryan Rowe, Abhay Sagare
Journal of Alzheimer's Disease. 2025-02-01
Press Mentions
Stunning Diagnostic Accuracy from a Plasma Protein Panel?June 11th, 2021
What Is My Risk for Alzheimer’s Disease?March 1st, 2018
Supplements Are a $30 Billion Racket—Here’s What Experts Actually RecommendFebruary 20th, 2018- Join now to see all
Grant Support
- Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic PopulationUNIVERSITY OF SOUTHERN CALIFORNIA2021–2026
- Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic PopulationUNIVERSITY OF SOUTHERN CALIFORNIA2021–2026
- Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, MexicoUNIVERSITY OF SOUTHERN CALIFORNIA2020–2025
- Clinical CoreNational Institute On Aging2010–2012
- UCLA Alzeheimer'S Disease Research CenterNational Institute On Aging2010
- Behavioral And Neurochemical Correlates Of Presenilin-1 Mutation StatusNational Center For Research Resources2006–2010
- A Phase II, Double-Blind, Placebo-Controlled Study Of The Safety And TolerabilNational Center For Research Resources2005–2009
- Clinical Trial: -KNational Center For Research Resources2008
- Evaluation Of The Safety, Tolerability And Impact On Biomarkers Of Anti-OxidaNational Center For Research Resources2007–2008
- #Name?National Center For Research Resources2007
- High Dose Supplements To Reduce Homocysteine And Slow The Rate Of CognitiveNational Center For Research Resources2005–2007
- Treatment Of Agitation/Psychosis In Dementia/Parkingsonism (Tap/Dap)National Center For Research Resources2005–2006
- KNational Center For Research Resources2005–2006
- Depression In Alzheimer'S Disease (DAD)National Center For Research Resources2005–2006
- FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003–2005
- FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
